FDA Home Page | Search
FDA Site | A-Z Index | Contact
FDA |
Note: Use your "Back" Arrow in your browser to return to the transcript
The following document was provided by Nellcor Perinatal and is not an official FDA document:
TYCO Healthcare
Nellcor
Nellcor Perinatal
4280 Hacienda Drive
Pleasanton, CA 94588
Tele 925 463-4509
Fax: 925 463- 4760
Dear ------
This letter clarifies existing N400 instructions for use and introduces additional changes to the clinical management protocol. These clarifications and changes are the result of thirteen reports of poor neonatal outcomes including two stillbirths, low Apgar scores, acidosis, and transient neonatal depression when the N400 was used. This letter is intended to strongly reemphasize the recommended management protocol for use with fetal pulse oximetry and to add additional recommendations which we think will be helpful to the clinician. These clarifications and changes are as follows:
Explanation for Changes to N400 Clinical Users Guide
Definition of "ominous" FHR
During the U.S. Multi-center Randomized Controlled Trial of the N400, the management protocol defined an ominous FHR pattern as:
Experience over the past two years suggests that the definition of "ominous" FHR pattern should be expanded to include additional patterns seen in conditions of significant metabolic acidosis, even when FSpO2 appears reassuring. This allows intervention in situations of profound 'dos's (hemodynamic compromise) at a t' e when the fetus is normally oxygenated.
The Fetal Heart Rate Classification (Table 1) has been modified to include two additional FHR patterns under the definition of "ominous" and to qualify the definition of prolonged deceleration. Under the new classification, ominous patterns are defined as:
The following footnote has been added to the FHR Classification to clarify that early intervention for a potentially ominous FHR is appropriate:
FN it is not necessary to wait for more than 7 minutes of prolonged deceleration before initiating intervention (e.g. evaluation of the cause, non-surgical interventions, and preparation for delivery), even with reassuring FSpO2.
When FSpO2 is not Available
When FSpO2 is not available despite sensor adjustment, the device has no adjunctive value. The fetus should be managed as though the FSpO2 were non-reassuring - that is, by FHR and clinical signs alone. No inferences regarding fetal status should be made on the basis of earlier FSpO2 values.
Emphasis on Adjunctive Role of FSpO2
FSpO2 is an instantaneous measure of fetal oxygenation and is valid only at the time of the measurement. Furthermore, FSpO2 is not a measure of fetal arterial blood pH.
It is possible that a fetus in labor may have experienced a period of significant hypoxia or ischemia prior to the initiation of monitoring. Metabolic acidosis may have occurred as a result of that exposure. If the conditions that caused the prior hypoxia have resolved, subsequent FSpO2 monitoring may be normal although the fetus may remain acidotic and the FHR nonreassuring. The reason for this is that fixed lactic acid may not clear the fetal system for a period of several hours.
Therefore, FSpO2 should only be used as an adjunct to FHR monitoring and other conventional clinical observations during labor. It should never be used as the sole means of assessing fetal status.
Recommended FHR Classification and Clinical Management Protocol Matrix
Tables 1 and 2 in the Enclosure are the updated clinical guidelines for using the N400. These guidelines were developed for the 1100 - subject, multi-center, U.S. randomized clinical trial of the N400 and also apply to commercial use of the device.
Clinicians should view Table 2 as recommendations that have been tested clinically, but which may not apply to every clinical situation. They are not intended to substitute for clinical judgment.
We hope that these clarifications are helpful to you in using the N400 system. If you have any questions about FHR classification and the use of fetal pulse oximetry, please contact your local Perinatal Clinical Consultant, or Technical Services (I -800-NELLCOR, press 3).
Sincerely,
Madeleine Bolling | David Swedlow, M.D, |
Product Marketing Manager | Medical Advisor |
Tyco Healthcare | Nellcor Perinatal |
Table 1: Fetal Heart Rate Classification
FHR Class | FHR Pattern |
---|---|
I | REASSURING Any FHR pattern that does not meet criteria for Class II or III. Typically, a Class I trace is characterized by a baseline between 110 and 160 bpm, with long term variability between 5 and 25 bpm, and either no decelerations or only early decelerations. |
II | NONREASSURING
Any one of the following for more than 15 minutes:
Any one of the following for more than 60 minutes
|
III | OMINOUS
|
a. Sinusoidal pattern is defined as regular oscillations about the baseline,
5-15 bpm in magnitude, with 2 to 5 cycles per minute on an otherwise normal
baseline with absent short-term variability.
b. Variable decelerations are to be timed from the beginning of the deceleration
to the end of the deceleration (i.e., more than 60 seconds in duration).
c.
Decreased variability not otherwise explained by the clinical situation (e.g.
narcotic administration).
d. It is not necessary to wait for more than 7 minutes of prolonged deceleration
before initiating intervention (e.g. evaluation of the cause, non-surgical
intervention, and preparation for delivery), even with reassuring FSpO2.
Table 2: Clinical Management Protocol Matrix
This matrix includes recommendations that have been tested clinically, but which may not apply to every clinical situation. They are not intended to substitute for clinical judgment.
FHR Classification Group | FHR and Oximeter |
||
---|---|---|---|
FSpO2 Not Reassuringa | FSpO2 Not Available Despite Sensor Adjustment | FSpO2 Reassuringb | |
Class I - Reassuring FHR Pattern | Continue labor unless otherwise indicatedc | Continue labor unless otherwise indicatedc | Continue labor unless otherwise indicated |
Class II - Nonreassuring FHR Pattern | Evaluate and manage nonreassuring FHRc | Evaluate and manage nonreassuring FHRc | Continue to labor unless otherwise indicatedc |
Class III - Ominous FHR Pattern | Deliver | Deliver | Deliver |
a. FSpO2 Not Reassuring - FSpO2 remains below 30% between contractions or
no value available, despite sensor adjustment.
b. FSpO2 Reassuring - FSpO2 returns to a value >= 30% between contractions.
c. All corrective, non-operative interventions should be applied as described
in Fetal Evaluation
Protocol (pages 14-16 of the Clinical Use Guide).
CDRH Home | CDER Home | CBER Home
FDA Home Page | Search FDA
Site | A-Z Index | Contact
FDA | Privacy | Accessibility
Center for Devices and Radiological Health (CDRH)